默沙东

周四，美国食品和药物管理局（FDA）表示，他们正在调查可能存在于默沙东公司目前最畅销的药品“欣流”与自杀事件之间的一种联系。

The Food and Drug Administration said Thursday it is investigating a possible link between Merck 's best-selling Singulair and suicide .

默沙东公司经理强调，FDA的调查只是基于一些报道，并没有临床研究做基础。而这也正是评估药品安全的标准。

Merck officials stressed that the FDA 's inquiry is based on reports , not clinical studies & which are the standard tool for evaluating drug safety .

其核心内容是以跨国医药公司默沙东制药（MSD）为案例，总结默沙东在中国医药行业中，培育核心竞争力的途径和方法。

This is the core of the pharmaceutical multinational pharmaceutical company Merck Sharp & Dohme ( MSD ) as a case , summarized in the Merck pharmaceutical industry in China , cultivating core competitiveness of ways and means .

这个合作项目由中国卫生部与美国著名制药公司默沙东共同发起的。

China 's Ministry of Health and the multinational drug company Merck Sharp and Dohme will fund the programme .

默沙东生产组30例服复方依那普利片的剂量、服法、疗程均与国产组相同。

The dosage , use and courses of treatment of MSD group were the same as those of domestic group .